肝脏BMAL1/AKT/脂生成轴通过促进PPARα通路保护小鼠抵抗酒精性肝病
研究探讨肝细胞昼夜节律蛋白BMAL1在酒精性肝病(ALD)中的作用。肝特异性敲除Bmal1小鼠乙醇饮食后脂肪变性和肝损伤更严重,同时从头脂生成和脂肪酸氧化受抑,补充合成PPARα配体可逆转;通过组成性活跃AKT恢复从头脂生成或过表达ChREBP可增加脂肪酸氧化并部分减轻乙醇诱导的脂肪肝和肝损伤。结论:BMAL1通过偶联ChREBP诱导的从头脂生成与PPARα介导的脂肪酸氧化保护小鼠抵抗ALD。
要点
- 肝细胞BMAL1对保护小鼠抵抗酒精性肝病是必要且充分的。
- Bmal1-LKO小鼠乙醇饮食后脂肪变性和肝损伤更严重,从头脂生成和脂肪酸氧化同时受抑。
- 补充合成PPARα配体、组成性活跃AKT恢复从头脂生成或过表达ChREBP可增加脂肪酸氧化并减轻肝损伤。
核心结论
- BMAL1在肝细胞中对酒精性肝病具有保护作用。
- BMAL1在饮酒期间的保护作用取决于其将ChREBP诱导的从头脂生成与PPARα介导的脂肪酸氧化偶联的能力。
研究设计与样本
- 研究采用肝特异性Bmal1敲除(Bmal1-LKO)或Bmal1敲低小鼠,给予乙醇饮食。
- 通过补充合成PPARα配体、组成性活跃AKT恢复从头脂生成、过表达ChREBP或SREBP-1c进行干预。
主要发现
- 乙醇饮食喂养的Bmal1-LKO或Bmal1敲低小鼠发生更严重的肝脂肪变性和肝损伤,同时从头脂生成和脂肪酸氧化均受抑制。
- 补充合成PPARα配体可挽救Bmal1-LKO小鼠的上述抑制。
- 通过组成性活跃AKT恢复Bmal1-LKO小鼠肝脏从头脂生成,不仅升高肝脏脂肪酸氧化,还减轻乙醇诱导的脂肪肝和肝损伤。
- 在Bmal1-LKO小鼠肝脏过表达脂生成转录因子ChREBP(而非SREBP-1c)也增加脂肪酸氧化并部分减少乙醇诱导的脂肪肝和肝损伤。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Alcohol liver disease (ALD) is one of the major chronic liver diseases worldwide, ranging from fatty liver, alcoholic hepatitis, cirrhosis, and potentially, hepatocellular carcinoma. Epidemiological studies suggest a potential link between ALD and impaired circadian rhythms, but the role of hepatic circadian proteins in the pathogenesis of ALD remains unknown. Here we show that the circadian clock protein BMAL1 in hepatocytes is both necessary and sufficient to protect mice from ALD. Ethanol diet-fed mice with liver-specific knockout (Bmal1-LKO) or depletion of Bmal1 develop more severe liver steatosis and injury as well as a simultaneous suppression of both de novo lipogenesis and fatty acid oxidation, which can be rescued by the supplementation of synthetic PPARα ligands. Restoring de novo lipogenesis in the liver of Bmal1-LKO mice by constitutively active AKT not only elevates hepatic fatty acid oxidation but also alleviates ethanol-induced fatty liver and liver injury. Furthermore, hepatic over-expression of lipogenic transcription factor ChREBP, but not SREBP-1c, in the liver of Bmal1-LKO mice also increases fatty acid oxidation and partially reduces ethanol-induced fatty liver and liver injury. Conclusion: we identified a protective role of BMAL1 in hepatocytes against ALD. The protective action of BMAL1 during alcohol consumption depends on its ability to couple ChREBP-induced de novo lipogenesis with PPARα-mediated fatty oxidation. (Hepatology 2018).
引用
- Zhang D, Tong X, Nelson BB, et al. The hepatic BMAL1/AKT/lipogenesis axis protects against alcoholic liver disease in mice via promoting PPARα pathway. Hepatology. 2018. PMID: 29534306. doi:10.1002/hep.29878
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。